A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation

[1]  Bill B. Chen,et al.  F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. , 2012, Blood.

[2]  G. Bishop,et al.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions , 2011, Immunological reviews.

[3]  Bill B. Chen,et al.  FBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrest , 2011, Cell cycle.

[4]  Bill B. Chen,et al.  F box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest , 2011, Oncogene.

[5]  Bill B. Chen,et al.  Calmodulin Antagonizes a Calcium-Activated SCF Ubiquitin E3 Ligase Subunit, FBXL2, To Regulate Surfactant Homeostasis , 2011, Molecular and Cellular Biology.

[6]  H. Habelhah.  Emerging complexity of protein ubiquitination in the NF-κB pathway. , 2010, Genes & cancer.

[7]  Cheng Luo,et al.  SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.

[8]  C. Harrison.  Sepsis: Calming the cytokine storm , 2010, Nature Reviews Drug Discovery.

[9]  F. He,et al.  Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation , 2010, Molecular and Cellular Biochemistry.

[10]  Dean Y. Li,et al.  Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza , 2010, Science Translational Medicine.

[11]  Oliver Soehnlein,et al.  Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile , 2010, The Journal of experimental medicine.

[12]  X. Yang,et al.  Suppression of tumor necrosis factor receptor associated factor (TRAF)-2 attenuates the proinflammatory and proliferative effect of aggregated IgG on rat renal mesangial cells. , 2010, Cytokine.

[13]  Qiang Sun,et al.  The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation , 2009, PLoS pathogens.

[14]  M. Pagano,et al.  SnapShot: F Box Proteins II , 2009, Cell.

[15]  J. Keats,et al.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling , 2008, Nature Immunology.

[16]  M. Yamashita,et al.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.

[17]  Tomoki Chiba,et al.  PML Activates Transcription by Protecting HIPK2 and p300 from SCFFbx3-Mediated Degradation , 2008, Molecular and Cellular Biology.

[18]  B. Lamothe,et al.  The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKL* , 2008, Journal of Biological Chemistry.

[19]  T. Hirano,et al.  c-Cbl-Dependent Monoubiquitination and Lysosomal Degradation of gp130 , 2008, Molecular and Cellular Biology.

[20]  Shengbin Li,et al.  Novel mutations in ubiquitin-specific protease 26 gene might cause spermatogenesis impairment and male infertility. , 2007, Asian journal of andrology.

[21]  G. Bishop,et al.  Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. , 2007, Immunity.

[22]  P. Lyu,et al.  Preparation, crystallization and preliminary X-ray analysis of XC2382, an ApaG protein of unknown structure from Xanthomonas campestris. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[23]  Timothy Cardozo,et al.  Systematic analysis and nomenclature of mammalian F-box proteins. , 2004, Genes & development.

[24]  E. Neufeld,et al.  Hemoglobin Jamaica plain--a sickling hemoglobin with reduced oxygen affinity. , 2004, The New England journal of medicine.

[25]  Timothy Cardozo,et al.  The SCF ubiquitin ligase: insights into a molecular machine , 2004, Nature Reviews Molecular Cell Biology.

[26]  H. Shu,et al.  TRAF7 Potentiates MEKK3-induced AP1 and CHOP Activation and Induces Apoptosis* , 2004, Journal of Biological Chemistry.

[27]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[28]  N. Mazloum,et al.  Identification of a Novel Protein, PDIP38, That Interacts with the p50 Subunit of DNA Polymerase δ and Proliferating Cell Nuclear Antigen* , 2003, The Journal of Biological Chemistry.

[29]  M. Walsh,et al.  TRAF‐Mediated TNFR‐Family Signaling , 2002, Current protocols in immunology.

[30]  S. Elledge,et al.  Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex , 2002, Nature.

[31]  M. Hochstrasser.  All in the Ubiquitin Family , 2000, Science.

[32]  C Pigeon,et al.  cDNA cloning and expression analysis of new members of the mammalian F-box protein family. , 2000, Genomics.

[33]  J. Inoue,et al.  Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. , 2000, Experimental cell research.

[34]  M. Vidal,et al.  Identification of a family of human F-box proteins , 1999, Current Biology.

[35]  M. Peter,et al.  Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Granger,et al.  Immunopathologic responses to non-lethal sepsis. , 1999, Shock.

[37]  S. Lederman,et al.  TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation. , 1999, Molecular immunology.

[38]  Mike Tyers,et al.  One Ring to Rule a Superfamily of E3 Ubiquitin Ligases , 1999, Science.

[39]  J. Inoue,et al.  TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Surrey,et al.  Analysis of 5' flanking regions of the gamma globin genes from major African haplotype backgrounds associated with sickle cell disease. , 1990, The Journal of clinical investigation.

[41]  J. Dodge,et al.  Letter: Heterozygote advantage in cystic fibrosis. , 1975, Lancet.

[42]  D. Gairdner.  HETEROZYGOTE ADVANTAGE IN CYSTIC FIBROSIS , 1975, The Lancet.

[43]  J. Fine.  Letter: Bacteraemic shock. , 1974, Lancet.

[44]  M. Karin,et al.  Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines , 2010, Nature Immunology.

[45]  M. Pagano,et al.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. , 2004, Nature.